Encompass Health Corporation
EHCHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeEncompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The $12.24B market capitalization puts EHC squarely in large-cap range for its industry. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Market Cap
$12.24B
Beta
0.60
P/E (TTM)
19.82
P/E (Fwd)
18.58
EPS (TTM)
$6.26
EPS (Fwd)
$6.68
ROE
25.0%
ROA
9.8%
Cash
$107.7M
Total Debt
$2.84B
Free CF
$229.9M
52W Change
-1.6%
Annual Financials
Cash vs Debt
Where EHC stands vs its 150-day and 200-day moving averages
As of the October 15, 2026 close, EHC finished 14.89% above its 150-day moving average ($110.16) and 16.69% above its 200-day moving average ($108.46). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is EHC overbought or oversold?
At the October 15, 2026 close, EHC's RSI(14) was 62.6, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Encompass Health Corporation carries $2.84B in total debt against $107.7M in cash reserves — debt is roughly 26.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $229.9M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 25.0% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 9.8% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $4.35B (2022) to $5.94B (2025), reflecting a 36% increase over the period.
The relatively low beta of 0.60 suggests EHC is a less volatile holding compared to the broader index. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Encompass Health Corporation and its sector.